Description
EMPAFLO M Tablets 12.5mg + 500mg (30’s pack) combine Empagliflozin and Metformin to support effective management of type 2 diabetes mellitus. Each tablet contains 12.5mg of Empagliflozin, an SGLT2 inhibitor that helps eliminate excess glucose through the kidneys, and 500mg of Metformin, which decreases hepatic glucose production and enhances insulin sensitivity.
This dual-action formula aids in controlling blood sugar levels, assists with weight management, and may provide cardiovascular benefits. The 30-tablet pack offers a convenient supply for ongoing therapy.
Manufactured under stringent quality standards, EMPAFLO M Tablets ensure safety, efficacy, and consistent therapeutic effects. Patients should adhere to prescribed dosages and complement treatment with a balanced diet and regular exercise for optimal results.
Reviews
There are no reviews yet.